OBJECTIVES: To determine if a re-transurethral resection (TUR), in the presence or absence of muscle at the first TUR in patients with T1-high grade (HG)/Grade 3 (G3) bladder cancer, makes a difference in recurrence, progression, cancer specific (CSS) and overall survival (OS). PATIENTS AND METHODS: In a large retrospective multicentre cohort of 2451 patients with T1-HG/G3 initially treated with bacille Calmette-Guérin, 935 (38%) had a re-TUR. According to the presence or absence of muscle in the specimen of the primary TUR, patients were divided in four groups: group 1 (no muscle, no re-TUR), group 2 (no muscle, re-TUR), group 3 (muscle, no re-TUR) and group 4 (muscle, re-TUR). Clinical outcomes were compared across the four groups. RESULTS: Re-TUR had a positive impact on recurrence, progression, CSS and OS only if muscle was not present in the primary TUR specimen. Adjusting for the most important prognostic factors, re-TUR in the absence of muscle had a borderline significant effect on time to recurrence [hazard ratio (HR) 0.67, P = 0.08], progression (HR 0.46, P = 0.06), CSS (HR 0.31, P = 0.07) and OS (HR 0.48, P = 0.05). Re-TUR in the presence of muscle in the primary TUR specimen did not improve the outcome for any of the endpoints. CONCLUSIONS: Our retrospective analysis suggests that re-TUR may not be necessary in patients with T1-HG/G3, if muscle is present in the specimen of the primary TUR.

The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin

GONTERO, Paolo;PISANO, Francesca;ODERDA, Marco;
2016-01-01

Abstract

OBJECTIVES: To determine if a re-transurethral resection (TUR), in the presence or absence of muscle at the first TUR in patients with T1-high grade (HG)/Grade 3 (G3) bladder cancer, makes a difference in recurrence, progression, cancer specific (CSS) and overall survival (OS). PATIENTS AND METHODS: In a large retrospective multicentre cohort of 2451 patients with T1-HG/G3 initially treated with bacille Calmette-Guérin, 935 (38%) had a re-TUR. According to the presence or absence of muscle in the specimen of the primary TUR, patients were divided in four groups: group 1 (no muscle, no re-TUR), group 2 (no muscle, re-TUR), group 3 (muscle, no re-TUR) and group 4 (muscle, re-TUR). Clinical outcomes were compared across the four groups. RESULTS: Re-TUR had a positive impact on recurrence, progression, CSS and OS only if muscle was not present in the primary TUR specimen. Adjusting for the most important prognostic factors, re-TUR in the absence of muscle had a borderline significant effect on time to recurrence [hazard ratio (HR) 0.67, P = 0.08], progression (HR 0.46, P = 0.06), CSS (HR 0.31, P = 0.07) and OS (HR 0.48, P = 0.05). Re-TUR in the presence of muscle in the primary TUR specimen did not improve the outcome for any of the endpoints. CONCLUSIONS: Our retrospective analysis suggests that re-TUR may not be necessary in patients with T1-HG/G3, if muscle is present in the specimen of the primary TUR.
2016
118
1
44
52
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1464-410X
bladder cancer; high grade; progression; re-TUR; recurrence; T1G3; Urology
Gontero, Paolo; Sylvester, Richard; Pisano, Francesca; Joniau, Steven; Oderda, Marco; Serretta, Vincenzo; Larré, Stéphane; Di Stasi, Savino; Van Rhijn, Bas; Witjes, Alfred J.; Grotenhuis, Anne J.; Colombo, Renzo; Briganti, Alberto; Babjuk, Marek; Soukup, Viktor; Malmström, Per-Uno; Irani, Jacques; Malats, Nuria; Baniel, Jack; Mano, Roy; Cai, Tommaso; Cha, Eugene K.; Ardelt, Peter; Vakarakis, John; Bartoletti, Riccardo; Dalbagni, Guido; Shariat, Shahrokh F.; Xylinas, Evanguelos; Karnes, Robert J.; Palou, Joan
File in questo prodotto:
File Dimensione Formato  
The impact of re-transurethral...pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 355.4 kB
Formato Adobe PDF
355.4 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1636375
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 110
  • ???jsp.display-item.citation.isi??? 99
social impact